Precipio Inc (NASDAQ:PRPO) fell 6.3% during trading on Friday . The stock traded as low as $0.15 and last traded at $0.15. 1,547,938 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 3,101,815 shares. The stock had previously closed at $0.16.
The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.13 and a current ratio of 0.14.
ILLEGAL ACTIVITY WARNING: “Precipio (PRPO) Stock Price Down 6.3%” was first published by BBNS and is the sole property of of BBNS. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://baseballnewssource.com/2019/03/24/precipio-prpo-stock-price-down-6-3/3305843.html.
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.